DICLOFENAC
| Brand name | ZORVOLEX |
|---|---|
| Active ingredient | DICLOFENAC |
| Strength | 35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2013 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9180095 | April 2030 | use U-55 |
| 9186328 | April 2030 | use U-55 |
| 8999387 | April 2030 | use U-55 |
| 8679544 | April 2030 | product |
| 9180096 | April 2030 | product |
| 9173854 | April 2030 | product |
| 9017721 | April 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.